Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 83 results.
User Information
Export Records
  1. 1.   Carboxyl-terminal modulator protein induces apoptosis by regulating mitochondrial function in lung cancer cells
  2. Hwang, S. K.; Minai-Tehrani, A.; Yu, K. N.; Chang, S. H.; Kim, J. E.; Lee, K. H.; Park, J.; Beck, G. R.; Cho, M. H.
  3. International Journal of Oncology. 2012, May; 40(5): 1515-1524.
  1. 2.   JS-K, a Glutathione S-Transferase-Activated Nitric Oxide Donor With Antineoplastic Activity in Malignant Gliomas
  2. Weyerbrock, A.; Osterberg, N.; Psarras, N.; Baumer, B.; Kogias, E.; Werres, A.; Bette, S.; Saavedra, J. E.; Keefer, L. K.; Papazoglou, A.
  3. Neurosurgery. 2012, Feb; 70(2): 497-510.
  1. 3.   One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)thiazole: A unique, highly active antimicrotubule agent
  2. Romagnoli, R.; Baraldi, P. G.; Cara, C. L.; Salvador, M. K.; Bortolozzi, R.; Basso, G.; Viola, G.; Balzarini, J.; Brancale, A.; Fu, X. H.; Li, J.; Zhang, S. Z.; Hamel, E.
  3. European Journal of Medicinal Chemistry. 2011, Dec; 46(12): 6015-6024.
  1. 4.   Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer
  2. Koutros, S.; Andreotti, G.; Berndt, S. I.; Barry, K. H.; Lubin, J. H.; Hoppin, J. A.; Kamel, F.; Sandler, D. P.; Burdette, L. A.; Yuenger, J.; Yeager, M.; Alavanja, M. C. R.; Freeman, L. E. B.
  3. Pharmacogenetics and Genomics. 2011, Oct; 21(10): 615-623.
  1. 5.   Population pharmacokinetic analysis of sorafenib in patients with solid tumours
  2. Jain, L.; Woo, S.; Gardner, E. R.; Dahut, W. L.; Kohn, E. C.; Kummar, S.; Mould, D. R.; Giaccone, G.; Yarchoan, R.; Venitz, J.; Figg, W. D.
  3. British Journal of Clinical Pharmacology. 2011, Aug; 72(2): 294-305.
  1. 6.   Isolation and Characterization of the CYP2D6 Gene in Felidae with Comparison to Other Mammals
  2. Schenekar, T.; Winkler, K. A.; Troyer, J. L.; Weiss, S.
  3. Journal of Molecular Evolution. 2011, Feb; 72(2): 222-231.
  1. 7.   Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L)
  2. Mayeenuddin, L. H.; Yu, Y.; Kang, Z.; Helman, L. J.; Cao, L.
  3. Oncogene. 2010, Dec; 29(48): 6367-6377.
  1. 8.   Synthesis and Antitumor Activity of 1,5-Disubstituted 1,2,4-Triazoles as Cis-Restricted Combretastatin Analogues
  2. Romagnoli, R.; Baraldi, P. G.; Cruz-Lopez, O.; Cara, C. L.; Carrion, M. D.; Brancale, A.; Hamel, E.; Chen, L. C.; Bortolozzi, R.; Basso, G.; Viola, G.
  3. Journal of Medicinal Chemistry. 2010, May; 53(10): 4248-4258.
  1. 9.   Energetic determinants of protein binding specificity: Insights into protein interaction networks
  2. Carbonell, P.; Nussinov, R.; del Sol, A.
  3. Proteomics. 2009 9(7): 1744-1753.
  1. 10.   The C-terminal transmembrane domain of Bcl-x(L) mediates changes in mitochondrial morphology
  2. Zheng, J. Y.; Tsai, Y. C.; Kadimcherla, P.; Zhang, R.; Shi, J.; Oyler, G. A.; Boustany, N. N.
  3. Biophysical Journal. 2008 94(1): 286-297.
  1. 11.   Caspase-dependent cleavage disrupts the ERK cascade scaffolding function of KSR1
  2. McKay, M. M.; Morrison, D. K.
  3. Journal of Biological Chemistry. 2007, Sep; 282(36): 26225-26234.
  1. 12.   A novel synthetic analogue of a constituent of Isodon excisus inhibits transcription of CYP1A1,-1A2 and-1B1 by preventing activation of the aryl hydrocarbon receptor
  2. Sienkiewicz, P.; Ciolino, H. P.; Leslie, B. J.; Hergenrother, P. J.; Singletary, K.; Yeh, G. C.
  3. Carcinogenesis. 2007, May; 28(5): 1052-1057.
  1. 13.   The pregnane X receptor gene-humanized mouse: A model for investigating drug-drug interactions mediated by cytochromes P450 3A
  2. Ma, X.; Shah, Y.; Cheung, C.; Guo, G. L.; Feigenbaum, L.; Krausz, K. W.; Idle, J. R.; Gonzalez, F. J.
  3. Drug Metabolism and Disposition. 2007, Feb; 35(2): 194-200.
  1. 14.   Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines
  2. Glover, C. J.; Rabow, A. A.; Isgor, Y. G.; Shoemaker, R. H.; Covell, D. G.
  3. Biochemical Pharmacology. 2007, Feb; 73(3): 331-340.
  1. 15.   Overexpression of proline oxidase induces proline-dependent and mitochondria-mediated apoptosis
  2. Hu, C. A. A.; Donald, S. P.; Yu, J.; Lin, W. W.; Liu, Z. H.; Steel, G.; Obie, C.; Valle, D.; Phang, J. M.
  3. Molecular and Cellular Biochemistry. 2007, Jan; 295(1-2): 85-92.
  1. 16.   Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats
  2. Moon, K. H.; Hood, B. L.; Kim, B. J.; Hardwick, J. P.; Conrads, T. P.; Veenstra, T. D.; Song, B. Y. J.
  3. Hepatology. 2006, Nov; 44(5): 1218-1230.
  1. 17.   Status of the world's smallest mammal, the bumble-bee bat Craseonycteris thonglongyai, in Myanmar
  2. Pereira, M. J. R.; Rebelo, H.; Teeling, E. C.; O'Brien, S. J.; Mackie, I.; Bu, S. S. H.; Swe, K. M.; Mie, K. M.; Bates, P. J. J.
  3. Oryx. 2006, Oct; 40(4): 456-463.
  1. 18.   Small molecule inhibitors of Apaf-1-related caspase-3/-9 activation that control mitochondrial-dependent apoptosis
  2. Malet, G.; Martin, A. G.; Orzaez, M.; Vicent, M. J.; Masip, I.; Sanclimens, G.; Ferrer-Montiel, A.; Mingarro, I.; Messeguer, A.; O Fearnhead, H.; Perez-Paya, E.
  3. Cell Death and Differentiation. 2006, Sep; 13(9): 1523-1532.
  1. 19.   A nuclear DNA phylogeny of the woolly mammoth (Mammuthus primigenius)
  2. Capelli, C.; MacPhee, R. D. E.; Roca, A. L.; Brisighelli, F.; Georgiadis, N.; O'Brien, S. J.; Greenwood, A. D.
  3. Molecular Phylogenetics and Evolution. 2006, Aug; 40(2): 620-627.
  1. 20.   Modeling dioxygen binding to the non-heme iron-containing enzymes
  2. Nemukhin, A. V.; Grigorenko, B. L.; Topol, I. A.; Burt, S. K.
  3. International Journal of Quantum Chemistry. 2006, Aug; 106(10): 2184-2190.
  1. 21.   Intracellular nucleotides act as critical prosurvival factors by binding to cyctochrome c and inhibiting apoptosome
  2. Chandra, D.; Bratton, S. B.; Person, M. D.; Tian, Y. A.; Martin, A. G.; Ayres, M.; Fearnhead, H. O.; Gandhi, V.; Tang, D. G.
  3. Cell. 2006, Jun; 125(7): 1333-1346.
  1. 22.   On the nature of oxoiron (IV) intermediate in dioxygen activation by non-heme enzymes
  2. Nemukhin, A. V.; Topol, I. A.; Cachau, R. E.; Burt, S. K.
  3. Theoretical Chemistry Accounts. 2006, MAY; 115(5): 348-353.
  1. 24.   Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors
  2. Stauffer, J. K.; Khan, T.; Salcedo, R.; Hixon, J. A.; Lincoln, E.; Back, T. C.; Wigginton, J. M.
  3. Journal of Immunotherapy. 2006, MAR-APR; 29(2): 151-164.
  1. 25.   Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients
  2. Lepper, E. R.; Baker, S. D.; Permenter, M.; Ries, N.; van Schaik, R. H. N.; Schenk, P. W.; Price, D. K.; Ahn, D.; Smith, N. F.; Cusatis, G.; Ingersoll, R. G.; Bates, S. E.; Mathijssen, R. H. J.; Verweij, J.; Figg, W. D.; Sparreboom, A.
  3. Clinical Cancer Research. 2005, OCT 15; 11(20): 7398-7404.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel